Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Menicon CoSTU:5FR 89 Net Margin % is -1.36% as of Mar. 2026. GuruFocus rates STU:5FR with a GF Score™ of 89/100 and a GF Value™ of €9.12. The stock has 3 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Menicon Co ranks better than 56.79% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Menicon Co's Net Income for the
three
months ended in Mar. 2026 was €-2.4 Mil. Menicon Co's Revenue for the
three
months ended in Mar. 2026 was €172.7 Mil. Therefore, Menicon Co's net margin for the quarter that ended in Mar. 2026 was -1.36%.
The historical rank and industry rank for Menicon Co's Net Margin % or its related term are showing as below:
STU:5FR'
s Net Margin % Range Over the Past 10 Years
Min: 3.47 Med: 4.66 Max: 6.9
Current: 4.71
STU:5FR's Net Margin % is ranked better than 56.79% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs STU:5FR: 4.71
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Menicon Co Net Margin % Related Terms
Menicon Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Menicon Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:5FR vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Menicon Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Menicon Co Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Menicon Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Menicon Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Menicon Co (STU:5FR) has a Net Margin % of -1.36% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Menicon Co and its competitors. Over the past decade, Menicon Co's Net Margin % has ranged from 3.47 to 6.90. According to the industry distribution chart, Menicon Co ranks #353 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 43.2%.
Is Menicon Co's Net Margin % too high?
Menicon Co's current Net Margin % is -1.36%. Over the past 10 years, this metric has ranged from a low of 3.47 to a high of 6.90. Based on the distribution chart, Menicon Co ranks #353 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Menicon Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Menicon Co's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Menicon Co ranks #353 out of 817 companies for Net Margin %. This puts Menicon Co in the upper half of its industry. The industry median Net Margin % is 2.05. Historically, Menicon Co's own Net Margin % has ranged from 3.47 to 6.90 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.05, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Menicon Co and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Menicon Co's current Net Margin % is -1.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Menicon Co stock overvalued right now?
Menicon Co (STU:5FR) has a current Net Margin % of -1.36%. The stock's GF Value™ is €9.12, compared to a current price of €9.20 — trading 0.9% above its estimated fair value. The current Net Margin % is -1.36%. Menicon Co's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Menicon Co (STU:5FR), the current Net Margin % is -1.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Menicon Co (STU:5FR) Overvalued in 2026?
Based on GuruFocus' analysis, Menicon Co stock appears to be overvalued.
The current stock price of €9.20 is trading 0.9% above its estimated GF Value™ of €9.12.
Key valuation signals for STU:5FR:
Net Margin %: -1.36%
GF Value™: €9.12 vs. price of €9.20 (0.9% above fair value)
No single metric tells the full story. See the STU:5FR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Menicon Co Ltd is a contact lens manufacturing company. It is involved in manufacturing, sales, export, and import of contact lenses and other medical goods, manufacturing and sales of medical instruments, sales of medical supplies and research and development of intraocular lenses. The firm's products include soft lenses, gas permeable lenses and lens care products.
89GF Score
Get the complete analysis for STU:5FR
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:5FR has been successfully added to your 
